Aquisição de ADALImumab 40 mg/0.4 ml Sol inj Caneta 0.4 ml SC - Abbvie

ID 11067757 · Portal BASE
Price
Base Price
€19,200 .00
Effective Price
€19,200 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Vila Franca de Xira
Bidder Count
1
Winner
ABBVIE, LDA
NIF 510229050
Company
Competition
1 bidder recorded
ABBVIE, LDA
NIF 510229050
Dates
Publication
06 Dec 2024
Celebration
05 Dec 2024
Contracting Entity
Unidade Local de Saúde do Estuário do Tejo, E. P. E.
NIF 516487493
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 105 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
2426
Supplier
123
Number of Awards
3
Rule
A1 repeat direct award: 3 awards within 36 months
Detected 2026-03-06
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
19200.0
Threshold
20000.0
Rule
A5 threshold splitting: price within 5% below 20000.0
Detected 2026-03-06
A6 · Low Competition
A6_LOW_COMPETITION
MEDIUM
Rule
a6_single_bidder
Bidder count
1
Detected 2026-04-17